John Overdeck’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.23M Buy
400,986
+78,797
+24% +$1.34M 0.01% 1677
2026
Q1
$5.12M Buy
322,189
+24,834
+8% +$539K ﹤0.01% 1962
2025
Q4
$7.81M Buy
297,355
+139,747
+89% +$3.63M 0.01% 1303
2025
Q3
$3.56M Buy
157,608
+63,889
+68% +$1.32M 0.01% 1727
2025
Q2
$1.86M Buy
93,719
+40,615
+76% +$792K ﹤0.01% 1883
2025
Q1
$897K Sell
53,104
-26,978
-34% -$459K ﹤0.01% 2236
2024
Q4
$1.48M Sell
80,082
-2,749
-3% -$53.7K ﹤0.01% 1925
2024
Q3
$1.8M Buy
82,831
+60,624
+273% +$1.36M ﹤0.01% 1743
2024
Q2
$436K Buy
22,207
+12,707
+134% +$265K ﹤0.01% 2430
2024
Q1
$206K Buy
+9,500
New +$236K ﹤0.01% 2706
2023
Q1
Sell
-21,100
Closed -$628K 3030
2022
Q4
$628K Buy
+21,100
New +$755K ﹤0.01% 1925
2021
Q3
Sell
-5,000
Closed -$454K 4393
2021
Q2
$461K Buy
+5,000
New +$399K ﹤0.01% 3175
2020
Q1
Sell
-49,873
Closed -$643K 3334
2019
Q4
$643K Buy
+49,873
New +$593K ﹤0.01% 2588

Other funds holding FLGT

John Overdeck's FLGT Position: Q2 2026 in Review

John Overdeck increased its Fulgent Genetics (FLGT) stake by 24% in Q2 2026, buying an estimated $1.34M and bringing the position to 400,986 shares worth $8.23M. The position accounts for 0.01% of the portfolio, ranked #1677.

John Overdeck first reported a position in FLGT in Q4 2019 and has held it in 13 quarters since. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • John Overdeck held 400,986 shares of Fulgent Genetics worth $8.23M as of Q2 2026.
  • John Overdeck bought 78,797 Fulgent Genetics shares in Q2 2026, an estimated $1.34M.
  • Fulgent Genetics made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1677 holding.
  • John Overdeck first reported a position in Fulgent Genetics in Q4 2019 and has held it in 13 quarters since.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.